Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients

Breast Cancer Research and Treatment

Volumn 127, Issue 2, 2011, Pages 459-469

  Gounaris, I ^a   Provenzano, E ^a,b   Vallier, A L ^a   Hiller, L ^c   Iddawela, M ^a   Hilborne, S ^a   Taylor, K ^a   Britton, P ^a,b   Earl, H M ^a,b,d   Sinnatamby, R ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Pathological response; Volumetric ultrasound

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; GEMCITABINE; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; B SCAN; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG RESPONSE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PHASE 3 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM, RESIDUAL; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 79958212137     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1454-x     Document Type: Article

References (34)

1. SI Li JR Daling 2007 Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004 Cancer Epidemiol Biomarkers Prev 16 2773 2780 18086787 10.1158/1055-9965.EPI-07-0546 (Pubitemid 351196336)
2. P Ravdin K Cronin N Howlander C Berg R Chlebowski E Feuer, et al. 2007 The decrease in breast-cancer incidence in 2003 in the United States New Engl J Med 356 1670 1674 17442911 10.1056/NEJMsr070105 1:CAS:528:DC%2BD2sXksFCltL0%3D (Pubitemid 46631679)
3. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics 2009 CA Cancer J Clin 59 225 249 19474385 10.3322/caac.20006
4. D Mauri N Pavlidis J Ioannidis 2005 Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis J Natl Cancer Inst 97 188 194 15687361 10.1093/jnci/dji021 (Pubitemid 40277368)
5. DM Sataloff BA Mason AJ Prestipino UL Seinige CP Lieber Z Baloch 1995 Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome J Am Coll Surg 180 297 306 7874340 1:STN:280:DyaK2M7nvFemsQ%3D%3D
6. HM Kuerer LA Newman TL Smith FC Ames KK Hunt K Dhingra, et al. 1999 Clinical course of breast cancer patients with complete pathologic primary tumour and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy J Clin Oncol 17 460 469 10080586 1:CAS:528:DyaK1MXht1Wmur4%3D (Pubitemid 29075229)
7. KN Ogston ID Miller S Payne AW Hutcheon TK Sarkar I Smith, et al. 2003 A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival Breast 12 320 327 14659147 10.1016/S0960-9776(03)00106-1 (Pubitemid 37322062)
8. WF Symmans F Peintinger C Hatzis R Rajan H Kuerer V Valero, et al. 2007 Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy J Clin Oncol 25 4414 4422 17785706 10.1200/JCO.2007.10. 6823 (Pubitemid 350013847)
9. G von Minckwitz S Kummel P Vogel C Hanusch H Eidtmann J Hilfrich, et al. 2008 Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomised GeparTrio study J Natl Cancer Inst 100 552 562 10.1093/jnci/djn089
10. AB Chapgar LP Middleton AA Sahin P Dempsey AU Buzdar AN Mirza, et al. 2006 Accuracy of physical examination, mammography and ultrasonography in predicting residual pathologic tumour size in patients treated with neoadjuvant chemotherapy Ann Surg 243 257 264 10.1097/01.sla.0000197714.14318.6f (Pubitemid 43185446)
11. T Kanazawa S Akashi-Tanaka E Iwamoto M Takasugi T Shien T Kinoshita, et al. 2005 Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients Breast J 11 311 316 16174150 10.1111/j.1075-122X.2005.00003.x (Pubitemid 41726032)
12. AF Schott MA Roubidoux MA Helvie DF Hayes CG Kleer LA Newman, et al. 2005 Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy Breast Cancer Res Treat 92 231 238 16155794 10.1007/s10549-005-2510-1 1:CAS:528:DC%2BD2MXpvV2gsLo%3D (Pubitemid 41282819)
13. Q Zhu S Tannenbaum P Hedge M Kane C Xu SH Kurtzman 2008 Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization Neoplasia 10 1028 1040 18813360 1:CAS:528:DC%2BD1cXht1KgsL7L
14. G Singh P Kumar R Parshad A Seith S Thulkar N Hosten 2010 Role of color doppler indices in predicting disease-free survival of breast cancer patients during neoadjuvant chemotherapy Eur J Radiol 75 e158 e162 20071116 10.1016/j.ejrad.2009.12.027
15. HM Earl A Vallier L Hiller N Fenwick M Iddawela L Hughes-Davies, et al. 2009 Neo-tAnGo: a neoadjuvant randomized phase III trial of epirubicin/ cyclophosphamide and paclitaxel ± gemcitabine in the treatment of women with high-risk early breast cancer (EBC): first report of the primary endpoint, pathological complete response (pCR) J Clin Oncol 27 s522
16. R Prager A Gee G Treece L Berman 2002 Freehand 3D ultrasound without voxels: volume measurement and visualisation using the Stradx system Ultrasonics 40 109 115 12159915 10.1016/S0041-624X(02)00103-8 (Pubitemid 34545291)
17. G Treece A Gee R Prager CJ Cash L Berman 2003 High definition freehand 3D ultrasound Ultrasound Med Biol 29 529 546 12749923 10.1016/S0301-5629(02)00735- 4 (Pubitemid 36564839)
18. MH El-Didi MM Moneer HM Khaled S Makarem 2000 Pathological assessment of the response of locally advanced breast cancer to neoadjuvant chemotherapy and its implications for surgical management Surg Today 30 249 254 10752778 10.1007/s005950050054 1:STN:280:DC%2BD3c3hsVCmsA%3D%3D (Pubitemid 30187218)
19. S Huber M Medl M Vesely H Czembirek I Zuna S Delorme 2000 Ultrasonographic tissue characterization in monitoring tumour response to neoadjuvant chemotherapy in locally advanced breast cancer (work in progress) J Ultrasound Med 19 677 686 11026579 1:STN:280:DC%2BD3cvns1SntQ%3D%3D
20. SE Pinder E Provenzano E Earl IO Ellis 2007 Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy Histopathology 50 409 417 17448015 10.1111/j.1365-2559. 2006.02419.x 1:STN:280:DC%2BD2s3ktVCqtg%3D%3D (Pubitemid 46328171)
21. C Fiorentino A Berruti A Bottini M Bodini MP Brizzi A Brunelli, et al. 2001 Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease Breast Cancer Res Treat 69 143 151 11759820 10.1023/A:1012277325168 1:STN:280:DC%2BD38%2Fjt12htQ%3D%3D (Pubitemid 33079021)
22. K Akazawa Y Tamaki T Taguchi Y Tanji Y Miyoshi SJ Kim, et al. 2008 Potential of reduction in total tumour volume measured with 3-D MRI as a prognostic factor for locally-advanced breast cancer patients treated with primary chemotherapy Breast J 14 523 531 19000056 10.1111/j.1524-4741.2008. 00642.x
23. JH Choi HI Lim SK Lee WW Kim SM Kim E Cho, et al. 2010 The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: comparison with ultrasonography and magnetic resonance imaging J Surg Oncol 102 392 397 19877158 10.1002/jso.21424
24. J Keune D Jeffe M Schootman A Hoffman W Gillanders R Aft 2010 Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer Am J Surg 199 477 484 20359567 10.1016/j.amjsurg.2009.03.012
25. HD Bear S Anderson R Smith C Geyer EP Mamounas B Fisher, et al. 2003 Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 21 4165 4174 14559892 10.1200/JCO.2003.12.005 1:CAS:528:DC%2BD2cXpsVajtrg%3D (Pubitemid 46606185)
26. K Akazawa Y Tamaki T Taguchi Y Tanji Y Miyoshi SJ Kim, et al. 2006 Preoperative evaluation of residual tumour extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy Breast J 12 130 137 16509837 10.1111/j.1075-122X.2006.00220.x
27. C Balu-Maestro C Chapellier A Bleuse I Chanalet C Chauvel R Largillier 2002 Imaging in evaluation of response to neoadjuvant breast cancer treatment-benefits of MRI Breast Cancer Res Treat 72 145 152 12038705 10.1023/A:1014856713942 1:STN:280:DC%2BD383pvVSgsA%3D%3D (Pubitemid 34407209)
28. J Herrada R Iyer EN Atkinson N Sneige A Buzdar G Hortobagyi 1997 Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumour and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma Clin Cancer Res 3 1565 1569 9815844 1:STN:280:DyaK1M7htFSqsQ%3D%3D (Pubitemid 27431564)
29. V Londero M Bazzocchi C Del Frate F Puglisi C Di Loreto G Francescutti C Zuiani 2004 Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy Eur Radiol 14 1371 1379 14986052 10.1007/s00330-004- 2246-z (Pubitemid 39162217)
30. F Peintinger H Kuerer K Anderson J Boughey F Meric-Bernstam SE Singletary, et al. 2006 Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy Ann Surg Oncol 13 1443 1449 17028770 10.1245/s10434-006-9086-9 (Pubitemid 44749655)
31. D Segara IE Krop JE Garber E Winer L Harris JR Bellon, et al. 2007 Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol 96 474 480 17640031 10.1002/jso.20856 (Pubitemid 350044390)
32. S Singh S Pradhan RC Shukla MA Ansari A Kumar 2005 Color Doppler ultrasound as an objective assessment tool for chemotherapeutic response in advanced breast cancer Breast Cancer 12 45 51 15657523 10.2325/jbcs.12.45
33. P Forouhi JS Walsh TJ Anderson U Chetty 1994 Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment Br J Surg 81 223 225 8156342 10.1002/bjs.1800810221 1:STN:280:DyaK2c3gslOgug%3D%3D (Pubitemid 24122356)
34. S Akashi-Tanaka T Fukutomi T Watanabe N Katsumata T Nanasawa K Matsuo, et al. 2001 Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neo-adjuvant chemotherapy Int J Cancer 96 66 73 11241331 10.1002/1097-0215(20010220)96:1<66::AID-IJC7>3.0.CO;2-T 1:STN:280:DC%2BD3M3gtl2mtg%3D%3D (Pubitemid 32147686)